XML 58 R40.htm IDEA: XBRL DOCUMENT v3.24.1
Summary of Significant Accounting Policies, Accrued Expenses (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Accrued Expenses [Abstract]    
Incentive and other compensation costs $ 1,082,606 $ 85,191
Clinical trial costs 276,141 333,440
Director fees 60,210 0
Franchise taxes 12,160 26,886
Other 13,179 11,197
Accrued expenses $ 1,444,296 $ 456,714